Morgan Creek Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Morgan Creek Capital Management's REGN Position: Q2 2026 in Review
Morgan Creek Capital Management opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2026: 332 shares worth $207K. The stake represents 0.14% of the portfolio and ranks #14 among its holdings. This is a return to the name: Morgan Creek Capital Management previously reported a position in REGN as recently as Q4 2025.
Morgan Creek Capital Management first reported a position in REGN in Q4 2025 and has held it in 2 quarters since. The position peaked at $213K in Q4 2025. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Morgan Creek Capital Management held 332 shares of Regeneron Pharmaceuticals worth $207K as of Q2 2026.
- Regeneron Pharmaceuticals was a new Morgan Creek Capital Management position in Q2 2026.
- Regeneron Pharmaceuticals made up 0.14% of Morgan Creek Capital Management's portfolio in Q2 2026, its #14 holding.
- Morgan Creek Capital Management first reported a position in Regeneron Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
- Morgan Creek Capital Management's Regeneron Pharmaceuticals position peaked at $213K in Q4 2025.
- 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Morgan Creek Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.